NO EFFECT OF HEPATIC IMPAIRMENT ON THE PHARMACOKINETICS OF SERELAXIN, A RECOMBINANT HUMAN RELAXIN-2 IN DEVELOPMENT FOR THE TREATMENT OF ACUTE HEART FAILURE ArticleKobalava Z., Halabi A., Zahringer A., Pang Y., Dahlke M.Circulation. Vol. 128. 2013.
EFFICACY OF ANTIVIRAL TREATMENT OF CHRONIC HEPATITIS C WITH PEG-IFN ALPHA-2B AND RIBAVIRIN IN COMBINATION WITH METFORMIN IN PATIENTS WITH HCV-1 GENOTYPE AND INSULIN RESISTANCE ArticleKhafisova O.O., Tarasova O., Mazurchik N., Ogurtsov P.P.HEPATOLOGY. Vol. 58. 2013.